Olanzapine for prevention of chemotherapy-induced nausea and vomiting in children and adolescents: a multi-center, feasibility study
Crossref DOI link: https://doi.org/10.1007/s00520-017-3864-8
Published Online: 2017-08-30
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Flank, J.
Schechter, T.
Gibson, P.
Johnston, D. L.
Orsey, A. D.
Portwine, C.
Sung, L.
Dupuis, L. L.
Funding for this research was provided by:
Pediatric Oncology Group of Ontario
License valid from 2017-08-30